Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Stock Forecast

Stock Price Forecast

The 16 analysts that cover Jazz Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $207.19, which forecasts a 27.42% increase in the stock price over the next year. The lowest target is $150 and the highest is $247.

Price Target: $207.19 (+27.42%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$150	$207.19	$209	$247
Change	-7.75%	+27.42%	+28.53%	+51.90%

Analyst Ratings

The average analyst rating for Jazz Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	6	6	6	6	6	6
Buy	8	8	8	8	8	8
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joon Lee Truist Securities	Truist Securities	Strong Buy Maintains $220 → $230	Strong Buy	Maintains	$220 → $230	+41.44%	Jan 12, 2026
Ami Fadia Needham	Needham	Strong Buy Maintains $210 → $235	Strong Buy	Maintains	$210 → $235	+44.52%	Jan 12, 2026
David Amsellem Piper Sandler	Piper Sandler	Buy Reiterates $147 → $219	Buy	Reiterates	$147 → $219	+34.68%	Dec 10, 2025
Ashwani Verma UBS	UBS	Strong Buy → Hold Downgrades $163 → $188	Strong Buy → Hold	Downgrades	$163 → $188	+15.61%	Nov 24, 2025
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $170 → $235	Buy	Maintains	$170 → $235	+44.52%	Nov 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.31B

Increased by 6.00%

from 4.07B

Revenue Next Year

4.59B

Increased by 6.47%

from 4.31B

EPS This Year

8.23

Decreased by -4.87%

from 8.65

EPS Next Year

23.03

Increased by 179.88%

from 8.23

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.36B	3.09B	3.66B	3.83B	4.07B	4.31B	4.59B
Revenue Growth	9.34%	30.91%	18.26%	4.78%	6.12%	6.00%	6.47%
EPS	4.22	-5.52	-3.58	6.10	8.65	8.23	23.03
EPS Growth	-53.58%	-	-	-	41.75%	-4.87%	179.88%
Forward PE	-	-	-	-	-	19.76	7.06
No. Analysts	-	-	-	-	-	20	20

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	4.5B	5.0B
Avg	4.3B	4.6B
Low	4.1B	4.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	10.3%	15.1%
Avg	6.0%	6.5%
Low	0.8%	-6.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	8.80	31.55
Avg	8.23	23.03
Low	7.58	19.52

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	1.7%	283.5%
Avg	-4.9%	179.9%
Low	-12.4%	137.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.